Nissan Motor (OTC:NSANY) announced it will suspend new U.S. orders for its Mexican-built Infiniti QX50 and QX55 SUVs following the implementation of new auto tariffs by President Donald Trump. The Japanese automaker said the tariffs prompted the decision to pause orders of these models for the U.S. market. However, production will continue at the COMPAS joint venture plant in Mexico to serve other international markets.
This move highlights growing tensions in the auto industry over cross-border production and trade policy changes. The Infiniti QX50 and QX55 are popular luxury SUVs that have been assembled in Mexico to meet demand in the U.S. and globally. Nissan emphasized that this suspension only applies to U.S. orders and is not a production halt overall.
In a related update, Nissan said it will maintain both shifts of production for its Rogue SUV at the Smyrna, Tennessee plant. This decision reverses a previous plan announced in January to cut one of the shifts by the end of the month. The company cited changing market conditions as the reason for keeping both shifts active.
The Trump administration’s latest tariffs are part of a broader effort to bring more auto manufacturing back to the United States. However, automakers like Nissan, who rely on international supply chains, are facing difficult decisions about production and sales strategies.
With the Infiniti QX50 and QX55 off the U.S. order books for now, dealers and consumers may feel the impact in coming months. Nissan has not announced when or if U.S. orders for these models will resume.


Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Apple Turns 50: From Garage Startup to AI Crossroads
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



